BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 37823053)

  • 1. CD98 heavy chain as a prognostic biomarker and target for cancer treatment.
    Xia P; Dubrovska A
    Front Oncol; 2023; 13():1251100. PubMed ID: 37823053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The CD98 Heavy Chain Is a Marker and Regulator of Head and Neck Squamous Cell Carcinoma Radiosensitivity.
    Digomann D; Kurth I; Tyutyunnykova A; Chen O; Löck S; Gorodetska I; Peitzsch C; Skvortsova II; Negro G; Aschenbrenner B; Eisenhofer G; Richter S; Heiden S; Porrmann J; Klink B; Schwager C; Dowle AA; Hein L; Kunz-Schughart LA; Abdollahi A; Lohaus F; Krause M; Baumann M; Linge A; Dubrovska A
    Clin Cancer Res; 2019 May; 25(10):3152-3163. PubMed ID: 30670494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed.
    Digomann D; Linge A; Dubrovska A
    Autophagy; 2019 Oct; 15(10):1850-1851. PubMed ID: 31276435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino Acid Transport Associated to Cluster of Differentiation 98 Heavy Chain (CD98hc) Is at the Cross-road of Oxidative Stress and Amino Acid Availability.
    de la Ballina LR; Cano-Crespo S; González-Muñoz E; Bial S; Estrach S; Cailleteau L; Tissot F; Daniel H; Zorzano A; Ginsberg MH; Palacín M; Féral CC
    J Biol Chem; 2016 Apr; 291(18):9700-11. PubMed ID: 26945935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aryl hydrocarbon receptor-dependent up-regulation of the heterodimeric amino acid transporter LAT1 (SLC7A5)/CD98hc (SLC3A2) by diesel exhaust particle extract in human bronchial epithelial cells.
    Le Vee M; Jouan E; Lecureur V; Fardel O
    Toxicol Appl Pharmacol; 2016 Jan; 290():74-85. PubMed ID: 26621329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperation of Antiporter LAT2/CD98hc with Uniporter TAT1 for Renal Reabsorption of Neutral Amino Acids.
    Vilches C; Boiadjieva-Knöpfel E; Bodoy S; Camargo S; López de Heredia M; Prat E; Ormazabal A; Artuch R; Zorzano A; Verrey F; Nunes V; Palacín M
    J Am Soc Nephrol; 2018 Jun; 29(6):1624-1635. PubMed ID: 29610403
    [No Abstract]   [Full Text] [Related]  

  • 7. CD98hc in host-pathogen interactions: roles of the multifunctional host protein during infections.
    Vection S; O'Callaghan D; Keriel A
    FEMS Microbiol Rev; 2022 Sep; 46(5):. PubMed ID: 35595511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profile of CD98 heavy chain and L-type amino acid transporter 1 and its prognostic significance in colorectal cancer.
    Lee D; Kim HS; Kim HU; Song HJ; Lee C; Kim DY; Chun HM; Jang WY; Jang B
    Pathol Res Pract; 2022 Jan; 229():153730. PubMed ID: 34942513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drosophila expresses a CD98 transporter with an evolutionarily conserved structure and amino acid-transport properties.
    Reynolds B; Roversi P; Laynes R; Kazi S; Boyd CA; Goberdhan DC
    Biochem J; 2009 May; 420(3):363-72. PubMed ID: 19335336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD98hc (SLC3A2) drives integrin-dependent renal cancer cell behavior.
    Poettler M; Unseld M; Braemswig K; Haitel A; Zielinski CC; Prager GW
    Mol Cancer; 2013 Dec; 12():169. PubMed ID: 24359579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD98hc as a marker of radiotherapy-resistant cancer stem cells in head and neck squamous cell carcinoma.
    Kawasaki Y; Omori Y; Suzuki S; Yamada T
    Arch Med Sci; 2023; 19(6):1859-1868. PubMed ID: 38058706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD98hc (SLC3A2) loss protects against ras-driven tumorigenesis by modulating integrin-mediated mechanotransduction.
    Estrach S; Lee SA; Boulter E; Pisano S; Errante A; Tissot FS; Cailleteau L; Pons C; Ginsberg MH; Féral CC
    Cancer Res; 2014 Dec; 74(23):6878-89. PubMed ID: 25267066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LAT1 (SLC7A5) and CD98hc (SLC3A2) complex dynamics revealed by single-particle cryo-EM.
    Chiduza GN; Johnson RM; Wright GSA; Antonyuk SV; Muench SP; Hasnain SS
    Acta Crystallogr D Struct Biol; 2019 Jul; 75(Pt 7):660-669. PubMed ID: 31282475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic activation-related CD147-CD98 complex.
    Xu D; Hemler ME
    Mol Cell Proteomics; 2005 Aug; 4(8):1061-71. PubMed ID: 15901826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD98hc (SLC3A2) mediates integrin signaling.
    Feral CC; Nishiya N; Fenczik CA; Stuhlmann H; Slepak M; Ginsberg MH
    Proc Natl Acad Sci U S A; 2005 Jan; 102(2):355-60. PubMed ID: 15625115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryo-EM structure of the human L-type amino acid transporter 1 in complex with glycoprotein CD98hc.
    Lee Y; Wiriyasermkul P; Jin C; Quan L; Ohgaki R; Okuda S; Kusakizako T; Nishizawa T; Oda K; Ishitani R; Yokoyama T; Nakane T; Shirouzu M; Endou H; Nagamori S; Kanai Y; Nureki O
    Nat Struct Mol Biol; 2019 Jun; 26(6):510-517. PubMed ID: 31160781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD98 increases renal epithelial cell proliferation by activating MAPKs.
    Bulus N; Feral C; Pozzi A; Zent R
    PLoS One; 2012; 7(6):e40026. PubMed ID: 22768207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD147-CD98hc complex contributes to poor prognosis of non-small cell lung cancer patients through promoting cell proliferation via the PI3K/Akt signaling pathway.
    Fei F; Li X; Xu L; Li D; Zhang Z; Guo X; Yang H; Chen Z; Xing J
    Ann Surg Oncol; 2014 Dec; 21(13):4359-68. PubMed ID: 25084765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consensus mutagenesis approach improves the thermal stability of system x
    Oda K; Lee Y; Wiriyasermkul P; Tanaka Y; Takemoto M; Yamashita K; Nagamori S; Nishizawa T; Nureki O
    Protein Sci; 2020 Dec; 29(12):2398-2407. PubMed ID: 33016372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of CD98hc in Pancreatic Cancer and Its Role in Cancer Cell Behavior.
    Bianconi D; Fabian E; Herac M; Kieler M; Thaler J; Prager G; Unseld M
    J Cancer; 2022; 13(7):2271-2280. PubMed ID: 35517419
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.